Performance of GH Guardant Health | -19% in 12m
Compare GH with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Guardant Health with its related Sector/Index XLV
Performance Duell GH vs XLV
| TimeFrame | GH | XLV |
|---|---|---|
| 1 Day | 4.29% | 0.86% |
| 1 Week | 4.63% | 2.01% |
| 1 Month | 1.25% | 0.02% |
| 3 Months | -14.0% | -0.13% |
| 6 Months | -13.6% | 15.09% |
| 12 Months | -19.0% | 10.00% |
| YTD | -26.7% | 3.63% |
| Rel. Perf. 1m | 0.04 | |
| Rel. Perf. 3m | -4.49 | |
| Rel. Perf. 6m | -4.62 | |
| Rel. Perf. 12m | -3.82 |
Is Guardant Health a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Guardant Health (NASDAQ:GH) is currently (May 2024)
not a good stock to buy. It has a ValueRay Fundamental Rating of -49.91 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GH as of May 2024 is 15.66. This means that GH is currently overvalued and has a potential downside of -19.44% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GH as of May 2024 is 15.66. This means that GH is currently overvalued and has a potential downside of -19.44% (Sold with Premium).
Is GH a buy, sell or hold?
- Strong Buy: 11
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: GH is performing better - Values below 0%: GH is underperforming
Compare GH with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.63% | 1.09% | -34.32% | -47.39% |
| US NASDAQ 100 | QQQ | 1.32% | 1.52% | -33.19% | -57.00% |
| US Dow Jones Industrial 30 | DIA | 1.55% | -0.13% | -30.83% | -38.58% |
| German DAX 40 | DBXD | 0.30% | -1.90% | -34.95% | -35.58% |
| UK FTSE 100 | ISFU | 1.83% | -3.56% | -30.08% | -30.37% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.67% | -3.12% | -17.02% | -7.96% |
| Hongkong Hang Seng | HSI | 2.96% | -7.06% | -16.34% | -6.57% |
| Japan Nikkei 225 | EXX7 | 5.13% | 5.87% | -26.11% | -34.51% |
| India NIFTY 50 | INDA | 7.29% | 2.87% | -30.66% | -43.56% |
| Brasil Bovespa | EWZ | 4.41% | 4.71% | -17.24% | -35.34% |
GH Guardant Health vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.73% | 2.40% | -35.36% | -59.76% |
| Consumer Discretionary | XLY | 3.31% | 2.53% | -26.79% | -41.19% |
| Consumer Staples | XLP | 2.61% | -2.24% | -27.96% | -22.53% |
| Energy | XLE | 2.70% | 4.47% | -29.96% | -40.59% |
| Financial | XLF | 1.64% | 0.86% | -38.92% | -50.44% |
| Health Care | XLV | 2.62% | 1.23% | -28.65% | -28.97% |
| Industrial | XLI | 1.62% | 0.91% | -38.86% | -47.48% |
| Materials | XLB | 1.13% | 2.68% | -34.80% | -37.95% |
| Real Estate | XLRE | 1.31% | 4.44% | -27.10% | -25.03% |
| Technology | XLK | 0.71% | 2.44% | -31.06% | -56.60% |
| Utilities | XLU | -0.48% | -6.92% | -34.57% | -26.34% |
| Aerospace & Defense | XAR | 1.55% | -3.18% | -33.14% | -44.71% |
| Biotech | XBI | 3.91% | 4.15% | -47.21% | -22.56% |
| Homebuilder | XHB | 0.71% | 2.00% | -55.75% | -71.09% |
| Retail | XRT | 1.50% | 1.40% | -40.36% | -42.57% |
Does Guardant Health outperform its market, is GH a Sector Leader?
No, over the last 12 months Guardant Health (GH) made -18.97%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 10.00%.
Over the last 3 months GH made -14.02%, while XLV made -0.13%.
No, over the last 12 months Guardant Health (GH) made -18.97%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 10.00%.
Over the last 3 months GH made -14.02%, while XLV made -0.13%.
| Period | GH | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 1.25% | 0.02% | 0.16% |
| 3 Months | -14.02% | -0.13% | 4.11% |
| 12 Months | -18.97% | 10.00% | 28.42% |